IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CATTANEO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.194
AS - Asia 3.134
EU - Europa 2.751
SA - Sud America 581
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 11.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.093
CN - Cina 1.273
SG - Singapore 994
UA - Ucraina 774
DE - Germania 530
BR - Brasile 476
IT - Italia 451
HK - Hong Kong 322
FR - Francia 233
FI - Finlandia 186
VN - Vietnam 178
GB - Regno Unito 159
RU - Federazione Russa 151
TR - Turchia 119
IE - Irlanda 110
IN - India 71
BD - Bangladesh 53
CA - Canada 53
AR - Argentina 41
ZA - Sudafrica 32
SE - Svezia 28
MX - Messico 26
PL - Polonia 24
EC - Ecuador 22
IQ - Iraq 22
NL - Olanda 19
JP - Giappone 18
BE - Belgio 17
ES - Italia 16
PK - Pakistan 13
CO - Colombia 12
ID - Indonesia 12
LT - Lituania 11
AT - Austria 10
EU - Europa 10
PY - Paraguay 8
UZ - Uzbekistan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 6
AU - Australia 6
CL - Cile 6
DZ - Algeria 6
JM - Giamaica 6
NG - Nigeria 6
AZ - Azerbaigian 5
IL - Israele 5
MA - Marocco 5
PA - Panama 5
SA - Arabia Saudita 5
UY - Uruguay 5
AL - Albania 4
KE - Kenya 4
PH - Filippine 4
RS - Serbia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
EG - Egitto 3
IR - Iran 3
LB - Libano 3
MK - Macedonia 3
MU - Mauritius 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
RO - Romania 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
Totale 11.741
Salva come PNG Salva come JPEG
Città #
Jacksonville 536
Singapore 492
Fairfield 447
Woodbridge 422
Ashburn 364
Hong Kong 322
Houston 306
Beijing 274
Ann Arbor 239
San Jose 233
The Dalles 220
Princeton 212
Cambridge 209
Nanjing 198
Wilmington 198
Seattle 173
Chandler 143
New York 116
Dublin 110
Los Angeles 98
Istanbul 97
Lauterbourg 92
Helsinki 79
Nanchang 70
Milan 67
Ho Chi Minh City 63
Moscow 59
Des Moines 57
Hebei 57
Buffalo 52
Changsha 45
Shenyang 45
Hanoi 42
São Paulo 40
San Diego 35
Dallas 34
Kunming 34
Shanghai 33
Tianjin 32
Jiaxing 31
Lancaster 31
Jinan 28
Munich 28
San Francisco 28
Orem 21
Redondo Beach 21
Rome 20
Toronto 19
Brooklyn 18
Santa Clara 18
Atlanta 17
Brussels 17
Chicago 17
Hangzhou 17
Charlotte 16
Johannesburg 16
London 16
Rio de Janeiro 16
Tokyo 16
Nürnberg 15
Verona 15
Warsaw 15
Zhengzhou 15
Brescia 13
Mexico City 13
Haikou 12
San Mateo 12
Chennai 11
Lanzhou 11
Augusta 10
Belo Horizonte 10
Dhaka 10
Guayaquil 10
Kocaeli 10
Monmouth Junction 10
Ningbo 10
Phoenix 10
Curitiba 9
Dearborn 9
Frankfurt am Main 9
Guangzhou 9
Montreal 9
Taiyuan 9
Trieste 9
Da Nang 8
Denver 8
Miami 8
Taizhou 8
Turku 8
Vienna 8
Amsterdam 7
Baghdad 7
Boston 7
Brasília 7
Fuzhou 7
Genoa 7
Haiphong 7
Itajaí 7
Lucera 7
Manchester 7
Totale 7.149
Salva come PNG Salva come JPEG
Nome #
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 207
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 201
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 196
Desensibilizzazione orale alla rifampicina: descrizione di un nuovo protocollo. 162
CD3-CD4+ cells with a Th2-like pattern of cytokine production in the peripheral blood of a patient with cutaneous T cell lymphoma. 161
In vitro cell death of activated lymphocytes in Omenn's syndrome 156
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 154
Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection 153
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 150
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 149
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 149
Studio con TC ad alta risoluzione (HRCT) dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 146
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations 145
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 137
Circulating immune complexes in human acute leukaemia. 136
Esposizione a latice nelle aziende sanitarie: esperienze pratiche 135
I polimorfismi della metilentetraidrofolatoreduttasi (MTHFR) nel trattamento con methotrexate di pazienti con artrite reumatoide. Revisione della letteratura ed esperienza personale. 135
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 130
Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. 130
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 130
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 127
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 127
Prevenzione delle reazioni allergiche in pazienti sensibilizzati a latice 126
Anti beta2-glycoprotein I antibodies: clinical significance. 126
Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis. 125
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 125
Antiperinuclear factor in psoriatic arthropathy 122
Antinuclear antibodies in psoriatic arthritis and its subgroups 121
Nonorgan specific autoantibodies and heart damage. 121
Oesophageal manometry in early and definite systemic sclerosis. 120
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 120
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 117
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 117
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicentre prospective study. 116
Antiphospholipid antibodies and malignancies 116
EVALUATION OF NEUROLOGICAL MANIFESTATIONS IN 180 PATIENTS (PTS) WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) 116
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 116
Anticorpi antinucleo e artrite psoriasica 115
Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers 115
Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell-death 114
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis 114
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 114
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 114
Pregnancy in systemic sclerosis: a prospective study 114
Vasculite orticarioide: valutazione clinica, laboratoristica e terapeutica di 17 pazienti. 113
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 113
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 113
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 113
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA: FOCUS SULLE MANIFESTAZIONI NEUROLOGICHE 112
The anti-beta-2 glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. 111
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 111
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. 111
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA E LUPUS ERITEMATOSO SISTEMICO: DIFFERENZE E SOMIGLIANZE GENETIHE 110
Role of anti-prothrombin in antiphospholipid syndrome. 110
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 108
Chilblain Lupus Erythematosus (CL) è associato ad anticorpi anti SSA/Ro 108
MANIFESTAZIONI NEUROLOGICHE IN 180 PAZIENTI CON SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA. RUOLO DEI FATTORI DI RISCHIO CARDIOVASCOLARI 108
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 107
Systemic lupus erythematosus and pregnancy: a prospective study. 106
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis. 105
Antinuclear antibodies and psoriatic arthritis 105
Proliferazioni di cloni di tipo Th2 con fenotipo CD3- CD4+. Studio di 2 casi. 104
NEUROLOGICAL MANIFESTATIONS IN 169 PATIENTS WITH PAPS: WHICH SIGNIFICANCE FOR SMALL HYPERINTENSE WHITE MATTER LESIONS AT MAGNETIC RESONANCE IMAGING? 104
IL "PROFILO" DEGLI ANTICORPI ANTIFOSFOLIPIDI NELLA SINDROME PRIMARIA COME FATTORE DI RISCHIO PER EVENTI CLINICI: STUDIO DI 175 PAZIENTI 104
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of Low-dose versus high-dose intravenous cyclophosphamide. 102
Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. 102
Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. 101
ANTICORPI ANTIFOSFOLIPIDI E NEOPLASIE (aPL E NEOPLASIE) 100
Esophageal Dysfunction in Patients with Definite and Early Systemic Sclerosis 99
Anti-TNFalpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies. 97
Lymphadenopathic and oropharyngeal Kaposi's sarcoma in a drug addict with acquired immunodeficiency syndrome. Immunological abnormalities in peripheral blood and lymphoid tissue 97
PREGNANCY OUTCOMES IN WOMEN EXPOSED TO BIOLOGIC TREATMENT AND AFFECTED BY CHRONIC ARTHRITIS 96
Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow-up of 148 patients 95
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 94
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 94
The neonatal lupus erythematosus associated with isolated LA(SSB) antibodies. 94
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 93
Chillblain lupus erythematosus is associated with antibodies to SSA/Ro 93
IL METHOTREXATE (MTX) E I GENOTIPI DELLA METILENTETRAIDROFOLATOREDUTTASI (MTHFR) NEL TRATTAMENTO DI PAZIENTI ITALIANI CON MALATTIE REUMATICHE 93
Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. 93
[A high-resolution computed tomographic study of the pulmonary interstitium in systemic autoimmune diseases] Studio con tomografia computerizzata con alta risoluzione dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 91
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD). 90
Antiperinuclear factor (APF) in patients with psoriasic arthtritis 88
L'orticaria. 88
Oesophageal dysfunction in patients with definite and early systemic sclerosis 87
Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. 86
Chronic urticaria induced by eradication therapy of Helicobacter pilori: a case report. 85
Chilblain Lupus Erythematosus (CL) is associated with antibodies SSA/Ro 85
Esofagopatia sclerodermia in pazienti con sclerosi sistemica (SSC) “precoce” secondo Le Roy-Mesdger: confronto con altri subset di malattia. Studio clinico-manometrico di 181 pazienti 84
TERAPIE BIOLOGICHE E GRAVIDANZA: RISULTATI DI UNO STUDIO MULTICENTRICO ITALIANO 84
Lessons from the "Euro-Lupus Cohort". 84
Discordance for Systemic LupusErythematosus and Hyper IgE Syndrome in a pair of monozygous twins 83
Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients 83
Pretransplant antitumor conditioning (fTBI dose) correlates with bone marrow histology at day 0 in leukemic patients. 81
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 81
European Working Party on Systemic Lupus Erythematosus. Lessons from the "Euro-Lupus Cohort". 78
European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". 77
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases 75
Antiphospholipid antibodies and intestinal pathology 75
Lupus neonatale: manifestazioni cliniche e rischio di blocco cardiaco congenito in neonati da madri con anticorpi anti-Ro/SSA. 72
Totale 11.296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022763 29 152 14 56 12 27 22 56 39 87 70 199
2022/2023576 113 5 5 20 58 173 3 54 96 3 16 30
2023/2024630 53 19 41 31 13 102 21 23 216 3 1 107
2024/20251.500 2 7 5 177 218 116 99 52 149 127 362 186
2025/20263.171 345 503 245 515 305 192 421 125 162 245 88 25
Totale 11.810